Cargando…
Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise
SIMPLE SUMMARY: One of the major obstacles to anti-cancer therapy is the development of drug resistance that allows the cancer cell to adapt to the treatments and keep surviving. In this mini-review we attempt to give an overview of the adaptive responses and the cross-talk between them that could b...
Autores principales: | D’Orazi, Gabriella, Cirone, Mara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179898/ https://www.ncbi.nlm.nih.gov/pubmed/35681760 http://dx.doi.org/10.3390/cancers14112780 |
Ejemplares similares
-
Mutant p53 and Cellular Stress Pathways: A Criminal Alliance That Promotes Cancer Progression
por: D’Orazi, Gabriella, et al.
Publicado: (2019) -
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells
por: Garufi, Alessia, et al.
Publicado: (2023) -
The Impact of COVID-19 Infection in Cancer 2020–2021
por: D’Orazi, Gabriella, et al.
Publicado: (2022) -
NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis
por: Cirone, Mara, et al.
Publicado: (2022) -
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
por: Garufi, Alessia, et al.
Publicado: (2022)